Atlas Trials

MW151-101: First-in-human Study of MW151

Clinical trial NCT04120233 · COMPLETED

Trial details

NCT number
NCT04120233
Sponsor
Linda Van Eldik
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Drug Toxicity
Start date
2019-10-22
Primary completion
2021-09-16
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.